Keeneland, Fasig-Tipton, and Ocala Breeders’ Sales jointly announced important changes to policies regarding medication. They include restriction of non-steroidal anti-inflammatory drugs (NSAIDs) and a ban on bronchodilators at all 2-year-old sales, plus limited use of riding crops.
We continue to refine and adapt our policies with the overriding goal of protecting both the human and equine athletes while providing our customers the best opportunity for success at the racetrack.”
Source: BLOODHORSE, January 21, 2020. Link.